Disagreements over Duchenne therapy, management style may have led to ouster of key FDA official Tensions had been high before a top gene therapy regulator was placed on leave, alarming industry

https://www.statnews.com/2025/06/20/fda-ouster-top-gene-therapy-official-nicole-verdun-placed-on-leave-after-review-committee-canceled/